MMEL1 and early-onset autosomal dominant Alzheimer disease: Neprilysin-2, a protease that degrades the amyloid-β peptide [27], has been shown to play an important role in protecting against Alzheimer’s disease [28,29,30,31,32] and is positively associated with cognitive function in humans.